Effects of vitamin D supplementation on metabolic indices and hs-CRP levels in gestational diabetes mellitus patients: a randomized, double-blinded, placebo-controlled clinical trial.
10.4162/nrp.2016.10.3.328
- Author:
Roya YAZDCHI
1
;
Bahram Pourghassem GARGARI
;
Mohammad ASGHARI-JAFARABADI
;
Farnaz SAHHAF
Author Information
1. Department of Biochemistry and Diet Therapy, Faculty of Nutrition, Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
- Publication Type:Clinical Trial ; Randomized Controlled Trial ; Original Article
- Keywords:
Diabetes;
gestation;
vitamin D;
C-reactive protein
- MeSH:
Blood Glucose;
C-Reactive Protein;
Cholecalciferol;
Cholesterol;
Cholesterol, LDL;
Diabetes, Gestational*;
Fasting;
Female;
Gestational Age;
Homeostasis;
Humans;
Insulin;
Pregnancy;
Pregnant Women;
Vitamin D*;
Vitamins*
- From:Nutrition Research and Practice
2016;10(3):328-335
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/OBJECTIVES: Vitamin D plays an important role in the etiology of gestational diabetes mellitus (GDM). This study evaluated the effect of vitamin D supplementation on metabolic indices and hs-C-reactive protein (CRP) levels in GDM patients. SUBJECTS/METHODS: The study was a randomized, placebo-controlled, double-blinded clinical trial. Seventy-six pregnant women with GDM and gestational age between 24-28 weeks were assigned to receive four oral treatments consisting of 50,000 IU of vitamin D3 (n = 38) or placebo (n = 38) once every 2 weeks for 2 months. Fasting blood glucose (FG), insulin, HbA1c, 25-hydroxyvitamin D, lipid profile, hs-CRP, and homeostasis model assessment-insulin resistance (HOMA-IR) were measured before and after treatment. Independent and paired t-tests were used to determine intra- and intergroup differences, respectively. ANCOVA was used to assess the effects of vitamin D supplementation on biochemical parameters. RESULTS: Compared with the placebo group, in the vitamin D group, the serum level of 25-hydroxyvitamin D increased (19.15 vs. -0.40 ng/ml; P < 0.01) and that of FG (-4.72 vs. 5.27 mg/dl; P = 0.01) as well as HbA1c (-0.18% vs. 0.17%; P = 0.02) decreased. Improvements in the lipid profiles were observed in the vitamin D group, but without statistical significance. Significant increases in concentrations of hs-CRP, FG, HbA1c, total cholesterol, and LDL cholesterol were observed in the placebo group. No significant change in fasting insulin and HOMA-IR was observed in either group. CONCLUSIONS: In GDM patients, vitamin D supplementation improved FG and HbA1c but had no significant effects on lipid profile or hs-CRP.
